Evidence map›Paper›PMID 21877133›Full record

ArticleHuman genetics2012

Novel Alu retrotransposon insertion leading to Alström syndrome.

Mustafa Taşkesen, Gayle B Collin, Alexei V Evsikov, Ayşegül Güzel, R Köksal Özgül, Jan D Marshall, Jürgen K Naggert

Open access · greenAbstract readCase Reports
In one paragraph

Article in Human genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Case Report: Identification of two novelFrontiers in genetics · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Transposable elements in human genetic disease.Nature reviews. Genetics · 2019
    Review
  13. Article
  14. Warning SINEs: Alu elements, evolution of the human brain, and the spectrum of neurological disease.Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology · 2018
    Review
  15. Review
  16. Structural Variation ofGenomics & informatics · 2016
    Review
  17. Review
  18. Article
  19. Review
  20. Clinical utility gene card for: Alström Syndrome - update 2013.European journal of human genetics : EJHG · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Mustafa TaşkesenDepartment of Pediatrics, Dicle University School of Medicine, 21280 Diyarbakır, Turkey.
Gayle B Collin
Alexei V Evsikov
Ayşegül Güzel
R Köksal Özgül
Jan D Marshall
Jürgen K Naggert
Jackson Laboratory · USHacettepe University · TRDicle University · TR

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
MOLECULAR GENETIC CHARACTERIZATION OF ALSTROM SYNDROMER01HD036878 · NICHD · JACKSON LABORATORY · PI NAGGERT, JUERGEN K. · 1998 to 2011
$4.2M
NCI NIH HHS CA34196NCI NIH HHS P30 CA034196NICHD NIH HHS HD036878NICHD NIH HHS R01 HD036878
6 · The paper itself

Abstract

Alström syndrome is a clinically complex disorder characterized by childhood retinal degeneration leading to blindness, sensorineural hearing loss, obesity, type 2 diabetes mellitus, cardiomyopathy, systemic fibrosis, and pulmonary, hepatic, and renal failure. Alström syndrome is caused by recessively inherited mutations in the ALMS1 gene, which codes for a putative ciliary protein. Alström syndrome is characterized by extensive allelic heterogeneity, however, founder effects have been observed in some populations. To date, more than 100 causative ALMS1 mutations have been identified, mostly frameshift and non-sense alterations resulting in termination signals in ALMS1. Here, we report a complex Turkish kindred in which sequence analysis uncovered an insertion of a novel 333 basepair Alu Ya5 SINE retrotransposon in the ALMS1 coding sequence, a previously unrecognized mechanism underlying the mutations causing Alström syndrome. It is extraordinarily rare to encounter the insertion of an Alu retrotransposon in the coding sequence of a gene. The high frequency of the mutant ALMS1 allele in this isolated population suggests that this recent retrotransposition event spreads quickly, and may be used as a model to study the population dynamics of deleterious alleles in isolated communities.

Indexed as

Mutagenesis, InsertionalRetroelementsAlstrom SyndromeAlu ElementsChromosomes, Human, Pair 13FemaleHumansMalePedigreeRetroelements

Identifiers

PMID21877133
PMCPMC3264847
OpenAlexW2061321308

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.